ClinicalTrials.Veeva

Menu
I

ITB Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABP-671
Risankizumab
Iron

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Active, not recruiting
Gout
Other: Placebo
Drug: Allopurinol

This study is a large-scale investigation (Phase 3) into a new booster shot designed specifically for teenagers. The booster targets a particular var...

Active, not recruiting
COVID-19
Biological: Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
Biological: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine

Trial sponsors

AbbVie logo
A
American Regent logo
Exact Sciences Corporation logo
Mass General Brigham logo
Novavax logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems